Loading this company
Marsh & McLennan Companies, Inc.
MRSHPrices in USD
TickerWorth ScoreD41/100
What we think
Bank model: about $145.95 (range $123.10 to $179.23). Justified price-to-book, not a DCF.
Price
$188.50USD up +$0.15 (+0.08%)
Quoted · Prices are delayed.
Showing the last price we hold for this listing, recorded 2026-10-20 05:48 UTC (15 hours ago).
Why did it move today?
Nothing we can cite explains today’s move for this company.
What our bank model says
Bank-model estimate
$145.95
Range $123.10 to $179.23, for a cost of equity ±1% (6.9%–8.9%)
Price $188.50Priced · Prices are delayed.
Justified price-to-book, not a DCF. One formula’s estimate, not a price target.
Is it a good business?
- Valuation0 out of 100
- Growth83 out of 100
- Financial health33 out of 100
- Dividend100 out of 100
- Past performance83 out of 100
Bull, base, bear
Our forward range over 12 months is part of Pro. See plans
The street
We could not reach the analyst data just now.
What does it do?
Marsh & McLennan Companies, Inc., a professional services company, provides advisory services and insurance solutions to clients in the areas of risk, strategy, and people worldwide. The company operates through Risk and Insurance Services, and Consulting segments. It operates in the Insurance Brokers industry (Financial Services sector), headquartered in United States. The company employs roughly 95,000 people.
Key stats
52-week range$156.60–$198.49
- Open
- $186.20
- Day high
- $188.85
- Day low
- $186.00
- Previous close
- $188.35
- Volume
- 1,981,011 · 0.78× avg
- Average volume
- 2,549,873
- Market cap
- $89,954,320,384.00
- P/E (TTM)
- 23.04
- Earnings per share
- $8.18
- Beta
- 0.59
Prices are delayed. The feed does not say when these figures were taken.
What’s the latest?
- Reported quarterly or annual results
- Reported quarterly or annual results
- Signed a material agreement
- Reported shareholder vote results
- Reported quarterly or annual results
- Changed leadership or its board
- Changed leadership or its board
Top news
No recent headlines we can cite for this company.
Insider trades
The 90-day buying-and-selling read is part of Pro. See plans
- Brennan KatherineOption exercise · $99,406.06
- Brennan KatherineOpen-market sale ·
Not investment advice. TickerWorth Score is a model output.